Time tO last ChemotherApy and death in ovaRian cancEr patients: TO CARE/MITO 42 study, a retrospective analysis of italian MITO centers by Giulia Scotto, Anna Galatà, Robert Fruscio, Robert Fruscio, Giulia Besana, Fabio Landoni, Fabio Landoni, Luca Sgro, Alessandra Testi, Fulvio Borella, Gennaro Cormio, Gennaro Cormio, Mariangela Gianciotta, Mariangela Gianciotta, Francesca Arezzo, Francesca Arezzo, Brigida Anna Maiorano, Alessandra Baldoni, Marinella Destefanis, Jole Ventriglia, Sandro Pignata, Rita Chiari, Maria Carmen Azzolina, Ivano Raimondo, Ivano Raimondo, Margherita Turinetto, Valentina Tuninetti, Massimo Di Maio, Giorgio Valabrega

Get full text

A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images by Francesca Arezzo, Annarita Fanizzi, Rosanna Mancari, Emiliano Cocco, Samantha Bove, Maria Colomba Comes, Mariangela Gianciotta, Giorgia Lanza, Salvatore Lopez, Gerardo Cazzato, Erica Silvestris, Elsa Vitale, Enrico Vizza, Gennaro Cormio, Raffaella Massafra, Vera Loizzi

Get full text

Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oopho... by Vera Loizzi, Vera Loizzi, Maria Colomba Comes, Francesca Arezzo, Adriana Ionelia Apostol, Adriana Ionelia Apostol, Samantha Bove, Annarita Fanizzi, Robert Fruscio, Robert Fruscio, Vanesa Gregorc, Francesco Legge, Rosanna Mancari, Claudia Marchetti, Claudia Marchetti, Serena Negri, Serena Negri, Giorgia Russo, Laura Vertechy, Giovanni Scambia, Giovanni Scambia, Raffaella Massafra, Gennaro Cormio, Gennaro Cormio

Get full text